SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-14-438208
Filing Date
2014-12-10
Accepted
2014-12-10 06:06:59
Documents
2
Group Members
BIGARADE CORPOTSUKA AMERICA, INC.OTSUKA PHARMACEUTICAL CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC TO-C d835602dsctoc.htm SC TO-C 18913
2 EX-99.A.5.D d835602dex99a5d.htm EX-99.A.5.D 31689
  Complete submission text file 0001193125-14-438208.txt   52485
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Subject) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC TO-C | Act: 34 | File No.: 005-41430 | Film No.: 141276483
SIC: 2834 Pharmaceutical Preparations

Mailing Address SHINAGAWA GRAND CENTRAL TOWER 2-16-4 KONAN, MINATO-KU TOKYO M0 108-8242
Business Address SHINAGAWA GRAND CENTRAL TOWER 2-16-4 KONAN, MINATO-KU TOKYO M0 108-8242 011-81-3-6717-1400
Otsuka Holdings Co., Ltd. (Filed by) CIK: 0001586698 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0314
Type: SC TO-C